122 related articles for article (PubMed ID: 15575964)
21. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation.
Bandow K; Maeda A; Kakimoto K; Kusuyama J; Shamoto M; Ohnishi T; Matsuguchi T
Biochem Biophys Res Commun; 2010 Nov; 402(4):755-61. PubMed ID: 21036155
[TBL] [Abstract][Full Text] [Related]
22. TCL1 is overexpressed in patients affected by adult T-cell leukemias.
Narducci MG; Stoppacciaro A; Imada K; Uchiyama T; Virgilio L; Lazzeri C; Croce CM; Russo G
Cancer Res; 1997 Dec; 57(24):5452-6. PubMed ID: 9407948
[TBL] [Abstract][Full Text] [Related]
23. NIK and Cot cooperate to trigger NF-kappaB p65 phosphorylation.
Wittwer T; Schmitz ML
Biochem Biophys Res Commun; 2008 Jun; 371(2):294-7. PubMed ID: 18439422
[TBL] [Abstract][Full Text] [Related]
24. A
Hedl M; Abraham C
Gut; 2016 Nov; 65(11):1799-1811. PubMed ID: 26215868
[TBL] [Abstract][Full Text] [Related]
25. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao M; Yokota S; Iwai T; Kaneko H; Horiike S; Kashima K; Sonoda Y; Fujimoto T; Misawa S
Leukemia; 1996 Dec; 10(12):1911-8. PubMed ID: 8946930
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Cot activity in the proliferation of ALCL lymphoma cells.
Fernández M; Manso R; Bernaldo de Quirós F; López P; Martín-Duce A; Alemany S
Biochem Biophys Res Commun; 2011 Aug; 411(4):655-60. PubMed ID: 21741362
[TBL] [Abstract][Full Text] [Related]
27. Tpl2 kinase signal transduction in inflammation and cancer.
Vougioukalaki M; Kanellis DC; Gkouskou K; Eliopoulos AG
Cancer Lett; 2011 May; 304(2):80-9. PubMed ID: 21377269
[TBL] [Abstract][Full Text] [Related]
28. Luteolin, a novel natural inhibitor of tumor progression locus 2 serine/threonine kinase, inhibits tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells.
Kim JE; Son JE; Jang YJ; Lee DE; Kang NJ; Jung SK; Heo YS; Lee KW; Lee HJ
J Pharmacol Exp Ther; 2011 Sep; 338(3):1013-22. PubMed ID: 21705614
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.
Erny KM; Peli J; Lambert JF; Muller V; Diggelmann H
Oncogene; 1996 Nov; 13(9):2015-20. PubMed ID: 8934549
[TBL] [Abstract][Full Text] [Related]
30. TRAF6 and Src kinase activity regulates Cot activation by IL-1.
Rodríguez C; Pozo M; Nieto E; Fernández M; Alemany S
Cell Signal; 2006 Sep; 18(9):1376-85. PubMed ID: 16371247
[TBL] [Abstract][Full Text] [Related]
31. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
[TBL] [Abstract][Full Text] [Related]
32. Tpl-2/Cot and COX-2 in breast cancer.
Krcova Z; Ehrmann J; Krejci V; Eliopoulos A; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):21-5. PubMed ID: 18795070
[TBL] [Abstract][Full Text] [Related]
33. TRAF-dependent association of protein kinase Tpl2/COT1 (MAP3K8) with CD40.
Chan H; Reed JC
Biochem Biophys Res Commun; 2005 Mar; 328(1):198-205. PubMed ID: 15670770
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood.
Wu J; Green N; Hotchandani R; Hu Y; Condon J; Huang A; Kaila N; Li HQ; Guler S; Li W; Tam SY; Wang Q; Pelker J; Marusic S; Hsu S; Perry Hall J; Telliez JB; Cui J; Lin LL
Bioorg Med Chem Lett; 2009 Jul; 19(13):3485-8. PubMed ID: 19464884
[TBL] [Abstract][Full Text] [Related]
35. LPS-induced chemokine expression in both MyD88-dependent and -independent manners is regulated by Cot/Tpl2-ERK axis in macrophages.
Bandow K; Kusuyama J; Shamoto M; Kakimoto K; Ohnishi T; Matsuguchi T
FEBS Lett; 2012 May; 586(10):1540-6. PubMed ID: 22673523
[TBL] [Abstract][Full Text] [Related]
36. Involvement of Cot/Tp12 in bone loss during periodontitis.
Ohnishi T; Okamoto A; Kakimoto K; Bandow K; Chiba N; Matsuguchi T
J Dent Res; 2010 Feb; 89(2):192-7. PubMed ID: 20089988
[TBL] [Abstract][Full Text] [Related]
37. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
38. Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias.
Nearman ZP; Wlodarski M; Jankowska AM; Howe E; Narvaez Y; Ball E; Maciejewski JP
Br J Haematol; 2007 Jan; 136(2):237-48. PubMed ID: 17156396
[TBL] [Abstract][Full Text] [Related]
39. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
40. Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease.
George D; Salmeron A
Curr Top Med Chem; 2009; 9(7):611-22. PubMed ID: 19689369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
